IL37 and bladder transitional cell carcinoma: Dramatic IL-37 changes in BLCA tumors were not accompanied by major alterations in the expression levels of its receptor, SIGIRR; only marginal upregulations (~1.3-fold) of its mRNA in cancerous over non-cancerous bladder tissues were observed.